PRAC anticorps (N-Term)

N° du produit ABIN926529

Détail du produit anti-PRAC anticorps

Antigène: PRAC (Prostate Cancer Susceptibility Candidate (PRAC))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PRAC est non-conjugé

Application: Western Blotting (WB)

Purification: Purified

Immunogène: PRAC antibody was raised in rabbit using the N terminal of PRAC as the immunogen

Information d'application

Indications d'application: Optimal conditions should be determined by the investigator.

Commentaires:

PRAC Blocking Peptide, catalog no. 33R-2130, is also available for use as a blocking control in assays to test for specificity of this PRAC antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur PRAC

Antigène: PRAC (Prostate Cancer Susceptibility Candidate (PRAC))

Autre désignation: PRAC (PRAC Produits)

Synonymes: anticorps C17orf92, anticorps PRAC, anticorps PRAC1 small nuclear protein, anticorps PRAC1

Sujet: This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. Synonyms: Polyclonal PRAC antibody, Anti-PRAC antibody, prostate cancer susceptibility candidate antibody, C17orf92 antibody, MGC32520 antibody.